Improving the use of FDA Advisory Committees

New England Journal of Medicine

20 August 2022 - Advisory committees cannot support public trust in FDA decisions if the agency uses them inconsistently. 

Simple reforms could improve accountability, transparency, and trust.

Read New England Journal of Medicine Perspective

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation